Khot Rajashree S, Patil Adarsh, Rathod Bharatsing D, Patidar Madan, Joshi Prashant P
General Medicine, All India Institute of Medical Sciences, Nagpur, IND.
Cureus. 2023 Mar 17;15(3):e36298. doi: 10.7759/cureus.36298. eCollection 2023 Mar.
Mixed connective tissue disease (MCTD) is an overlap syndrome characterized by features of systemic lupus erythematosus, scleroderma, and polymyositis, along with the presence of the U1RNP antibody. A 46-year-old female patient presented with severe anemia, cough, and breathlessness, and was diagnosed with cold agglutinin disease, a type of autoimmune hemolytic anemia (AIHA). Autoimmune workup revealed MCTD by positive antinuclear and U1RNP antibodies. She had bilateral miliary mottling on X-ray and a tree-in-bud appearance on high-resolution computed tomography of the thorax, which were suggestive of pulmonary tuberculosis. Standard therapy with steroids was not advisable. She was subsequently started on anti-tuberculosis treatment (anti-Koch's therapy), followed by steroid therapy and immunosuppressive therapy after three weeks. The patient responded well to treatment, but after two months, she developed cytomegalovirus (CMV) retinitis. Adult-onset CMV disease may occur as a result of primary infection, reinfection, or activation of a latent infection. Although not directly related, it can occur as an atypical association in the setting of immunosuppressive therapy. Morbidity and mortality are significantly increased in this population secondary to infectious potentiation: immunosuppression causes infections, and infections cause AIHA. The management of MCTD and secondary AIHA and immunosuppression poses a therapeutic challenge.
混合性结缔组织病(MCTD)是一种重叠综合征,其特征为具有系统性红斑狼疮、硬皮病和多发性肌炎的特点,同时存在U1RNP抗体。一名46岁女性患者出现严重贫血、咳嗽和呼吸困难,被诊断为冷凝集素病,这是一种自身免疫性溶血性贫血(AIHA)。自身免疫检查通过抗核抗体和U1RNP抗体阳性显示为MCTD。她的胸部X线显示双侧粟粒状斑点,胸部高分辨率计算机断层扫描显示有树芽征,提示肺结核。使用类固醇的标准治疗并不可取。随后她开始接受抗结核治疗(抗科赫疗法),三周后开始使用类固醇疗法和免疫抑制疗法。患者对治疗反应良好,但两个月后,她出现了巨细胞病毒(CMV)视网膜炎。成人CMV疾病可能是原发性感染、再次感染或潜伏感染激活的结果。虽然没有直接关系,但它可作为免疫抑制治疗背景下的一种非典型关联出现。由于感染增强,该人群的发病率和死亡率显著增加:免疫抑制导致感染,而感染导致AIHA。MCTD及继发性AIHA和免疫抑制的管理带来了治疗挑战。